Skip to main content
Premium Trial:

Request an Annual Quote

Penn Wins $6M Grant from Parisian Foundation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – An international team of researchers led by the University of Pennsylvania's academic medical center, Penn Medicine, will use a $6 million grant from a French non-profit foundation to study genes that are involved in atherosclerotic cardiovascular disease, the university said today.

Scientists at Penn Medicine's Institute for Translational Medicine and Therapeutics will use the grant from the Fondation Leducq in Paris to look closely at the molecular mechanisms underlying genes that have been identified through genome-wide association studies for their potential involvement in coronary heart disease and heart attack.

Funded under the foundation's Transatlantic Networks of Excellence Program, the researchers plan to study six novel genes found by genome-wide association studies to be associated with heart disease in order to assess how they are involved in the processes that underlie cardiovascular disease and whether or not they are viable targets for therapeutic development.

The international research team includes experts in epidemiology, human genetics, molecular and cell biology, and animal physiology. The group includes scientists at Aachen University, Stanford University, Harvard Medical School, Massachusetts General Hospital, the University of Cambridge, the European Molecular Biology Laboratory, Columbia University, Lund University, the University of Western Ontario, the University of Heidelberg, and the University of Sheffield.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.